Home > PB Ratio > MANKIND PHARMA

MANKIND PHARMA
PB (Price/Book ) Ratio

The Current P/B Ratio of MANKIND PHARMA is 12.76.

Share Price ₹2,368.3Apr 26,2024
Market Cap ₹94,872.1 Cr
Book Value₹7,435.2 CrMar2023 - Consolidated Results
Price/Book 12.76xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of MANKIND PHARMA

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of MANKIND PHARMA is calculated as :

Current Market Cap [ ₹94,872.1 Cr] as on Apr 26,2024

(/) Book Value [ ₹7,435.2 Cr] based on Mar2023 - Consolidated Results

(=) P/B Ratio [ 12.76x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for MANKIND PHARMA , the investors are currently willing to pay '12.76 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of MANKIND PHARMA !

The chart below summarizes the trend in P/B Ratio of MANKIND PHARMA over the last five years.

Historical PB (Price/Book ) ratio chart of MANKIND PHARMA


PB Ratio Performance Analysis for MANKIND PHARMA

- MANKIND PHARMA 's latest p/b ratio is 12.76x.

- MANKIND PHARMA 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.00x.

- MANKIND PHARMA 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, MANKIND PHARMA 's p/b ratio peaked in Mar2023 at 0x.

- MANKIND PHARMA 's p/b ratio hit its five-year low in Mar2023 of 0x.


How does MANKIND PHARMA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
MANKIND PHARMA 7,435.1612.7694,872.1
SUN PHARMACEUTICAL INDUSTRIES LTD55,995.406.45360,920.0
CIPLA LTD23,346.004.87113,794.0
DR REDDYS LABORATORIES LTD23,140.404.51104,316.0
ZYDUS LIFESCIENCES LTD17,515.805.4595,380.9
DIVIS LABORATORIES LTD12,767.108.37106,860.0
TORRENT PHARMACEUTICALS LTD6,198.0714.6991,057.0
LUPIN LTD12,315.605.9873,642.4
AUROBINDO PHARMA LTD26,839.802.4766,278.5
ABBOTT INDIA LTD3,146.0217.4754,961.0
ALKEM LABORATORIES LTD9,044.696.4858,604.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs MANKIND PHARMA 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.47x
Max industry PB 17.47x
Median industry PB 6.45x
Average industry PB 8.14x



You may also like the below Video Courses